300298.SZ
三诺生物
SZSE · Healthcare · C 制造业 · CN
CNY 15.91
−0.87%Margins
Gross margin
49.7%
EBITDA margin
5.2%
EBIT margin
1.8%
Net margin
2.4%
FCF margin
5.5%
3.8%
Return on equity
2.0%
Return on assets
2.6%
Return on invested capital
0.83x
Asset turnover
CNY 454.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026